Response to roxadustat in a patient undergoing long-term dialysis and allergic to erythropoiesis-stimulating agents: A case report

BACKGROUND: Hypoxia-inducible factor prolyl hydroxylase inhibitor is a new class of drugs for treating renal anemia. It is a second-generation hypoxia-inducible factor prolyl hydroxylase-2 (PHD2) inhibitor. Roxadustat can effectively increase hemoglobin in patients with dialysis-dependent chronic ki...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Cai, Luo, Deng-Gui, Liu, Zhe-Yan, Yang, Dong, Wang, Dan-Dan, Xu, Yuan-Zhao, Yang, Jun, Fu, Bo, Qi, Ai-Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782933/
https://www.ncbi.nlm.nih.gov/pubmed/36568993
http://dx.doi.org/10.12998/wjcc.v10.i35.13122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782933/
https://www.ncbi.nlm.nih.gov/pubmed/36568993
http://dx.doi.org/10.12998/wjcc.v10.i35.13122

Ejemplares similares